BASELINE CALPROTECTIN DOES NOT PREDICT RESPONSE TO BIOLOGICAL THERAPY IN ULCERATIVE COLITIS

被引：0
|
作者：
Storey, D. [1 ]
Skouras, T. [1 ]
Bond, A. [1 ]
Dodd, S. [1 ]
Subramanian, S. [1 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Hosp Trust, Gastroenterol, Liverpool, Merseyside, England
来源：
GUT | 2017年 / 66卷
关键词：
D O I：
10.1136/gutjnl-2017-314472.473
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTH-074
引用
收藏
页码：A243 / A243
页数：1
相关论文
共 50 条
  • [21] ASSOCIATION BETWEEN BASELINE CALPROTECTIN SERUM LEVELS AND RESPONSE TO BIOLOGICAL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Martinez-Feito, A.
    Plasencia, C.
    Jochems, A.
    Navarro-Compan, V.
    Pascual-Salcedo, D.
    Hernandez-Breijo, B.
    Nozal, P.
    Peiteado, D.
    Villalba, A.
    Mezcua, A.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1286 - 1286
  • [22] Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis
    Hassan-Zahraee, Mina
    Ye, Zhan
    Xi, Li
    Dushin, Elizabeth
    Lee, Julie
    Romatowski, Jacek
    Leszczyszyn, Jaroslaw
    Danese, Silvio
    Sandborn, William J.
    Banfield, Christopher
    Gale, Jeremy D.
    Peeva, Elena
    Longman, Randy S.
    Hyde, Craig L.
    Hung, Kenneth E.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (09): : 1361 - 1370
  • [23] PHARMACOECONOMIC ASSESSMENT OF BIOLOGICAL THERAPY OF ULCERATIVE COLITIS
    Kaliyeva, S.
    Simohina, N.
    Yukhnevich, Y.
    Myasnikova, Z.
    Myasnikov, Y.
    VALUE IN HEALTH, 2018, 21 : S84 - S84
  • [24] RESPONSE OF ULCERATIVE COLITIS TO THERAPY WITH SALICYLAZOSULFAPYRIDINE
    MORRISON, LM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1953, 151 (05): : 366 - 368
  • [25] Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy
    Shibuya, Tomoyoshi
    Nomura, Kei
    Okahara, Koki
    Haga, Keiichi
    Nomura, Osamu
    Murakami, Takashi
    Uchida, Shino
    Kodani, Tomohiro
    Ishikawa, Dai
    Sakamoto, Naoto
    Ogihara, Tatsuo
    Osada, Taro
    Nagahara, Akihito
    MEDICAL SCIENCE MONITOR, 2019, 25 : 9855 - 9863
  • [26] Dietary Fat Intake, Fecal Calprotectin and Metabolomic Profiles Predict Relapse of Ulcerative Colitis
    Keshteli, Ammar H.
    van den Brand, Floris F.
    Wishart, David
    Mandal, Rupasri
    Bjorndahl, Trent C.
    Han, Beomsoo
    Baarda, Janis
    Kroeker, Karen I.
    Valcheva, Rosica
    Fedorak, Richard N.
    Madsen, Karen
    Dieleman, Levinus A.
    GASTROENTEROLOGY, 2014, 146 (05) : S430 - S431
  • [27] Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
    Park, S.
    Kang, Y.
    Koh, H.
    Kim, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S407 - S407
  • [28] Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis
    Kim, Seung
    Park, Sowon
    Kang, Yunkoo
    Koh, Hong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (01) : 17 - 21
  • [29] Clinical response and remission with vedolizumab across a range of baseline fecal calprotectin levels in ulcerative colitis: Results from GEMINI 1
    Reinisch, W.
    Lewis, J. D.
    Dassopoulos, T.
    Ginsburg, P.
    Sands, B. E.
    Feagan, B.
    Danese, S.
    Roseth, A. G.
    Rosario, M.
    Yang, H.
    Parikh, A.
    Bressler, B.
    Wyant, T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S47 - S47
  • [30] Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative Colitis
    Lasson, Anders
    Simren, Magnus
    Stotzer, Per-Ove
    Isaksson, Stefan
    Ohman, Lena
    Strid, Hans
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (03) : 576 - 581
12345